Introduction
The rapid aging of society is an emerging issue in many developed countries, including Japan, where life expectancy at birth was 83 years in 2015 (1) . The prevalence of colorectal cancer (CRC) has also been increasing yearly (2) , and there are more elderly patients with CRC. Surgery has a key role in the treatment of CRC in the elderly and the general population; however, safe surgery is particularly important for longer survival in elderly patients, who are generally frailer and have more comorbidities than younger adults (3) (4) (5) (6) (7) .
We assembled a database of 2065 elderly patients aged ≥80 years who underwent laparoscopic or open surgery for CRC at 41 hospitals between 2003 and 2007; all hospitals are members of the Japan Society of Laparoscopic Colorectal Surgery (8) . Using this database, we examined the safety and efficacy of laparoscopic surgery for colon cancer compared to those of open surgery. We concluded that laparoscopic surgery results in earlier recovery from surgery, has a lower morbidity, and offers similar survival outcomes to open surgery, making it an effective treatment option for elderly patients with CRC (8, 9) .
There are several other issues regarding surgical treatment for elderly patients with CRC. Adequate harvesting and examination of lymph nodes (LN) is a prognostic marker, and harvesting more than 12 LN has been recommended (10) (11) (12) . However, it remains uncertain whether radical LN dissection (LND) also contributes to a survival benefit in elderly patients, whose life expectancy is likely to be shorter than that of the general population. The number of harvested LN decreases as age increases (13, 14) , and only a few reports have supported a survival benefit of dissecting ≥12 LN in elderly patients with CRC (13) . Moreover, it is unclear if radical LND causes a higher morbidity rate than limited LND. Herein, we investigated the effect of the number of harvested LN on short-and long-term outcomes, based on analysis of our database of CRC surgeries for elderly patients aged ≥80 years old.
Materials and Methods
A search of the Japan Society of Laparoscopic Colorectal Surgery database generated 954 elderly patients aged ≥80 years who had undergone elective surgery for stage II or III colon cancer. An initial search generated more results, but 1111 elderly patients who had had stage 0, I, IV, or unknown rectal or colon cancer and who had undergone emergency or palliative surgery were excluded.
The 954 patients were divided into two groups based on the cut-off described in recent reports: <12 harvested LN and ≥12 harvested LN (10) (11) (12) . Subsequently, a propensity score method was used to balance the observed covariates between these groups because the cohorts were not randomly assigned to the <12 and ≥12 LN groups (15) . Multiple logistic regression analyses were used to select baseline variables associated with harvesting <12 or ≥12 LN. Covariates were used based on a priori selection and included age, sex, BMI, ASA score, Eastern Cooperative Oncology Group Performance Status (16) , previous abdominal surgery, surgical approach (open or laparoscopic), tumor location, tumor size, tumor differentiation, depth of tumor invasion, LN metastasis, TNM stage (Union for International Cancer Control, 7th edition (17)), tumor location, surgical procedure, and comorbidities. On the basis of propensity scores, one-to-one nearest neighbor matching without replacement was performed within a caliper width of 0.2 logit of the standard deviation.
Baseline characteristics were compared between the before-matching and matched cohorts, and short-term outcomes were examined in the matched cohorts. Shortterm outcomes examined were operative results (i.e. surgical duration, blood loss, and length of resected bowel), postoperative course (i.e. length of hospital stay, days to fluid diet, days to solid diet, and days to defecation), morbidity (i.e. surgical-site infection, bleeding, anastomotic leakage, ileus, cardiac complication, and delirium). Morbidities were assessed using the Common Terminology Criteria for Adverse Events ver. 4.0 (18). Summary statistics were calculated using frequencies and proportions for categorical data and using medians and interquartile ranges for continuous variables. A MannWhitney U-test was used for continuous data, and χ 2 and
Fisher's exact tests were used for categorical data. Survival outcomes were compared between the matched cohorts by log-rank test and are summarized as Kaplan-Meier curves and hazards ratios with 95% confidence intervals. Overall survival (OS), relapse-free survival (RFS), and CRC-specific survival (CSS) were evaluated, with the events for each type of survival defined as allcause death, all-cause death or CRC relapse, and death resulting from CRC, respectively. Multivariate analyses for OS, RFS, and CSS were also performed, using a Cox proportional hazard model that included all variables with P < 0.1 in the matched cohort. Subset analysis of OS with each baseline factor was performed to identify the subgroup in which a greater harvest of LN would potentially be more beneficial.
All analyses were performed with SPSS ver. 22 (IBM, Armonk, USA) and R statistical software ver. R2.10.0 (R Foundation for Statistical Computing, Vienna, Austria). The current study was performed with the permission of the Ethics Committee of the JSLCR (the Japan Society of Laparoscopic Colorectal Surgery).
Results
Of the 954 patients, 331 and 623 had <12 and ≥12 harvested LN, respectively, and 293 were included in each cohort after propensity score matching. This model yielded a C-index of 0.651 (95% confidence interval: 0.613-0.689, P < 0.001), indicating an appropriate ability to differentiate between the two groups. For the prediction model, calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test, which showed good calibration (P = 0.440). Baseline characteristics were biased for sex, previous abdominal surgery, tumor size, tumor location, tumor differentiation, LN metastases, surgical approach, and UICC-TNM stage before matching (P < 0.10), but these differences were not present in the matched cohorts, except for tumor size (Table 1) . A statistical tendency remained for tumor location (P = 0.07 after matching), but there was no significant difference between rightand left-sided colon cancers.
A comparison of short-term outcomes found no significant differences in the amount of blood loss, postoperative recovery, and morbidities between the matched cohorts, but surgical duration and extent of resected bowel were higher in the ≥12 LN group (Table 2 ). In survival analysis of the matched cohorts, the ≥12 LN group had higher OS, RFS, and CSS than the <12 LN group (Figure 1) . In subset analysis of OS, hazard ratios almost uniformly favored the ≥12 LN group (Figure 2 ). The significant differences in tumor size and length of resected bowel might have influenced the number of harvested LN, and therefore, multivariate analysis including these three factors was performed. In this analysis, only the number of harvested LN was found to have affected OS, RFS, and CSS (Table 3) .
Discussion
Adequate LND and ≥12 harvested LN are prognostic factors in the general population (10) (11) (12) . In the current study, we found that harvesting ≥12 LN contributed to survival prolongation without increased risk of morbidity in elderly patients with colon cancer. Moreover, a subset analysis of OS showed that harvesting ≥12 LN had affected OS, even among patients aged 83 and older. This result suggests that there may be no indication for limited LND based on old age. Fewer harvested LN are thought to affect survival because of stage migration. In particular, if fewer LN are harvested in stage II disease, this likely influences stage migration if stage III disease has been misdiagnosed as stage II, and the opportunity for adjuvant chemotherapy may be lost. However, only 2 of 293 patients (0.7%) in the <12 LN group underwent chemotherapy, so these issues had little impact on survival. The low rate of adjuvant chemotherapy might have been because of the lack of evidence regarding its safety and efficacy in elderly patients with CRC during the study period. However, adjuvant chemotherapy is now widely performed in elderly patients with CRC and is safe and effective (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . Therefore, a study of cohorts including those who have undergone adjuvant chemotherapy is required in the near future.
There were several limitations in the study. First, the results indicated that LND should not be limited by old age, but the appropriate range of LND, such as complete mesocolonic excision and Japanese D2/D3 dissection (29-31), could not be determined because information on this range was not available in the database. Furthermore, the resected bowel length itself might have affected survival outcomes, and the number of harvested LN might have varied in accordance with this length, which was actually shorter in the <12 LN group. The impact of these factors on survival was evaluated in multivariate analyses with harvested LN and resected bowel length as covariates. Despite this limitation related to bowel length, we believe that our results are still valuable and that harvesting ≥12 LN appears to be an independent risk factor for OS.
Second, the number of harvested LN might have also been influenced by age, male gender, better differentiated tumor, larger and deeper tumor, location, inflammation or immunological response due to cancer, and the way the harvested LN were counted (32) (33) (34) (35) . Although some factors such as age, sex, tumor differentiation, T factor, and tumor location were balanced using a case-matching method and propensity score-and therefore did not influence comparisons of survival between the groups with <12 and ≥12 harvested LN- tumor size was larger in the ≥12 LN group. Moreover, tumor size did not affect survival outcomes in multivariate analyses. However, the prognostic value of harvesting ≥12 LN was not impaired because a larger tumor size, in general, does not seem to contribute to better prognosis. It should be noted that neither inflammatory markers, such as white blood cell count and C-reactive protein levels, nor the method for counting harvested LN was available from the original database, and therefore, they were not considered in the current study. These potential impacts should be examined in future studies. Third, some potential biases affected survival outcomes in this study. One potential bias was institutional bias. Although this was a multicenter study that included 41 institutions, they were all high-volume surgical centers for CRC. This could have influenced the short-and long-term outcomes even in such a high-risk group. To address this issue, future studies should compare the outcomes between high-volume centers and others by using the national clinical database. Another potential bias is genetic aberrations, such as frequency of microsatellite instable (MSI-high) colon cancer in the elderly. MSI-high colon cancers have been reported to have a better prognosis than microsatellite colon cancer, and MSI-high is predominantly seen in the elderly (36) (37) (38) . Consequently, the frequency of MSI-high colon cancer might differ between the ≥12 and <12 LN groups. Because microsatellite instable status was not examined in this study, we cannot know its impact. Genetic aberrations including MSI-high should be examined in future studies.
Fourth, the results of this study might have been influenced by potential confounders because of the retrospective design, although background characteristics were adjusted using propensity score matching. For example, although the selection criteria for the surgical procedure, especially regarding the area of LND (D2 or D3), seemed to be an important confounder, it depended on clinical stages, surgeons, institutional policies, and patients-information that was unavailable in the original database. Therefore, randomized controlled trials are favored to solve these issues, but elderly patients are generally a heterogeneous population with a wide variety of health conditions, comorbidities, and multiple malignancies; as such, they may not be suitable for randomized controlled trials. Additionally, there have been no previous reports on surgical outcomes in very old patients with CRC. Consequently, the results of this study may offer the best current evidence that harvesting ≥12 LN in elderly patients with CRC is as effective as it is in the general population.
In conclusion, we believe that limited LND should not be considered in elderly patients with CRC and that harvesting ≥12 LN contributes to survival prolongation without an increased risk of morbidity. A further study is needed to clarify the appropriate range of LND. 
